Return to search

Mitochondrial dysfunction in C. elegans model of Parkinson's disease

Parkinson’s disease (PD) is a devastating neurodegenerative disease and the second most
prevalent after Alzheimer’s disease. The most characteristic hallmark of Parkinson’s is
the presence of Lewy Bodies, clumps of aggregated α-synuclein protein, in the
Substantia Nigra. While much has been said and theorized about α-synuclein,
mitochondrial dysregulation in neurons of Parkinson’s patients is an equally important consideration due to the role that the mitochondria plays in supplying neurons with their energy needs through ATP. C. elegans is a non-vertebrate animal often used
to study aging and neurodegenerative disease due to its simple, well characterized
genome. This literature review aims to outline the genetic and some environmental
factors that cause mitochondrial dysregulation leading to the progressive
neurodegeneration witnessed in Parkinson’s, as modeled in C. elegans. Through a
select review of studies done on C. elegans homolog of genes associated with
mitochondrial function, this review aims to elucidate the mechanism by which each
mutation not only causes the deficits seen in PD on its own but also how it interacts
with other genes to worsen or alleviate symptoms. Ultimately, understanding these
pathways and mechanism will be crucial to discovering and creating new therapeutic
treatments and targets.

Identiferoai:union.ndltd.org:bu.edu/oai:open.bu.edu:2144/38668
Date10 October 2019
CreatorsMukerji, Shivali
ContributorsMoussavi, Mina, Offner, Gwynneth
Source SetsBoston University
Languageen_US
Detected LanguageEnglish
TypeThesis/Dissertation

Page generated in 0.0017 seconds